Macrophages, lipoprotein metabolism, and atherosclerosis: Insights from murine bone marrow transplantation studies

Current Opinion in Lipidology

Volumn 10, Issue 2, 1999, Pages 97-105

  Linton, MacRae F ^a,b   Fazio, Sergio ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; GENE TARGETING; LIPOPROTEIN METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BONE MARROW TRANSPLANTATION; FOAM CELLS; LEUKOCYTES; LIPOPROTEINS; MACROPHAGES; MICE; MODELS, BIOLOGICAL; RECEPTORS, LDL;

MURINAE;

EID: 0032892490     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199904000-00003     Document Type: Review

References (51)

1. Ross R. The pathogenesis of atherosclerosis-a perspective for the 1990s. Nature 1993; 362:801-809
2. Fazio S, Linton MF. Munne bone marrow transplantation as a novel approach to studying the role of macrophages in lipoprotein metabolism and atherogenesis. Trends Cardiovasc Med 1996; 6 58-65.
3. Linton MF, Gish R, Hubl ST, Butler E, Esquivel C, Bry WI, et al. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest 1991; 88:270-281
4. Blue M-L, Williams DL, Zucker S, Khan SA, Blum CB. Apolipoprotein E synthesis in human kidney, adrenal gland, and liver. Proc Natl Acad Sci USA 1983; 80:283-287.
5. Basu SK, Brown MS, Ho YK, Havel RJ, Goldstein JL. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci USA 1981; 78:7545-7549.
6. Plump AS, Smith JD, Hayek T, Aalto-Setälä, Walsh A, Verstuyft JG, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 71:343-353.
7. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258:468-471.
8. Linton MF, Atkinson JB, Fazio S. Prevention of atherosclerosis in apoE deficient • mice by bone marrow transplantation. Science 1995; 267:1034-1037. First report on the effect of macrophage apoE on lipoprotein metabolism and aortic atherosclerosis in the mouse.
9. Hasty AH, Linton MF, Fazio S Determination of the lowest serum apolipoprotein E level resulting in remnant clearance in mice. Circulation 1997; 96 (Suppl).1-104.
10. Boisvert WA, Spangerberg J, Curtiss LK. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest 1995; 96:1118-1124.
11. Van Eck M, Herijgers N, Yates J, Pearce NJ, Hoogerbrugge PM, Van Berkel TJ. • Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of apoE gene dosage on serum lipid concentrations, betaVLDL catabolism, and atherosclerosis. Arterioscl Thromb Vasc Biol 1997; 17-3117-3126. This study confirms the finding that macrophage apolipoprotein E promotes lipoprotein clearance. The authors examine the relationship between serum levels of apolipoprotein E and cholesterol in apolipoprotein E-deficient mice reconstituted with wild-type marrow, and the role of Kupffer cells in remnant lipoprotein metabolism is investigated.
12. Spangenberg J, Curtiss LK Influence of macrophage-derived apoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apoprotein E-deficient mice. Biochim Biophys Acta 1997; 1349:109-121.
13. Rubinsztein DC, Cohen JC, Berger GM, van der Westhuyzen DR, Coetzee GA, Gevers W. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest 1990; 86:1306-1312.
14. Kita T, Goldstein JL, Brown MS, Watanabe Y, Hornick CA, Havel RJ. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor Proc Natl Acad Sci USA 1982; 79:3623-3627.
15. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993; 92:883-893.
16. Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS. The two-receptor model of lipoprotein clearance: tests of the hypothesis in 'knock-out' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 1994; 91:4431-4435.
17. Willnow TE, Sheng Z, Ishibashi S, Herz J. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist Science 1994; 264:1471-1474.
18. Rohlmann A, Gotthardt M, Hammer RE, Herz J. Inducible inactivation of hepatic • LRP gene by Cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants J Clin Invest 1998; 101:689-695. Conditional gene-targeting was used to make a liver specific knockout of the LRP. The authors demonstrate unequivocally that the LRP gene plays a physiologic role in the clearance of chylomicron remnants by the liver.
19. Kowal RC, Herz J, Goldstein JL, Esser V, Brown MS. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci USA 1989, 86:5810-5814
20. Fazio S, Yao Z, McCarthy BJ, Rall SC Jr. Synthesis and secretion of apolipoprotein E occur independently of synthesis and secretion of apolipoprotein B-containing lipoproteins in HepG2 cells. J Biol Chem 1992; 267 6941-6945.
21. Shimano H, Namba Y, Ohsuga J, Kawamura M, Yamamoto K, Shimada M. et al. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J Clin Invest 1994; 93-2215-2223
22. Hamilton RL, Wong JS, Guo LSS, Krisans S, Havel RJ. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J Lipid Res 1990; 31:1589-1603.
23. Ji Z-S, Fazio S, Lee Y-L, Mahley RW. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem 1994; 269:2764-2772.
24. Brown MS, Herz J, Kowal RC, Goldstein JL. The low-density lipoprotein receptor-related protein: double agent or decoy? Curr Opin Lipidol 1991; 2.65-72.
25. Linton MF, Hasty AH, Babaev VR, Fazio S. Hepatic apoE expression is required • for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J Clin Invest 1998; 101:1726-1736 The approach of bone marrow transplantation was used to investigate the mechanism of hepatic remnant lipoprotein clearance by introducing extrahepatic apolipoprotein E into the circulation of mice deficient in expression of both apolipoprotein E and the LDLR. The results confirms the existence of the secretion capture mechanism in vivo and indicate that hepatic apolipoprotein E expression is required for remnant lipoprotein uptake in the absence of the LDLR.
26. Ji Z-S, Pitas RE, Mahley RW. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. J Biol Chem 1998; 273:13452-13460.
27. Pittman RC, Carew TE, Attie AD, Witztum JL, Watanabe Y, Steinberg D. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J Biol Chem 1982; 257:7994-8000.
28. Ho YK, Brown MS, Bilheimer DW, Goldstein JL. Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. J Clin Invest 1976, 58:1465-1474
29. Bilheimer DW, Ho YK, Brown MS, Anderson RGW, Goldstein JL. Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia. J Clin Invest 1978; 61:678-696.
30. Traber MG, Kayden HJ. Low density lipoprotein receptor activity in human monocyte-derived macrophages and its relation to atheromatous lesions. Proc Natl Acad Sci USA 1980; 77:5466-5470.
31. Knight BL, Soutar AK. Changes in metabolism of modified and unmodified low-density lipoproteins during the maturation of cultured blood monocyte-macrophages from normal and homozygous familial hypercholesterolemic subjects. Eur J Biochem 1982; 125:407-413
32. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983; 52.223-261.
33. Ho YK, Faust JR, Bilheimer DW, Brown MS, Goldstein JL. Regulation of cholesterol synthesis by low density lipoprotein in isolated human lymphocytes. Comparison of cells from normal subjects and patients with homozygous familial hypercholesterolemia and abetalipoproteinemia. J Exp Med 1977; 145:1531-1549.
34. Fazio S, Hasty AH, Carter KJ, Murray AB, Price JO, Linton MF. Leukocyte low • density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse J Lipid Res 1997; 38:391-400. In this study, reconstitution of LDLR ( -/-) mice with wild-type marrow and wild-type mice with LDLR ( -/-) marrow is shown to have no influence on plasma lipid and lipoprotein levels. The results indicate that leukocyte expression of the LDLR does not contribute significantly to plasma lipoprotein clearance.
35. Boisvert WA, Spangerberg J, Curtiss LK Role of leukocyte-specific LDL • receptors on plasma lipoprotein cholesterol and atherosclerosis in mice. J Lipid Res 1997; 17:340-347 Transplantation of LDLR ( -/-) mice with LDLR (+/+) marrow did not influence plasma lipids. Interestingly, macrophages staining for the LDLR were detected in the atherosclerotic lesions, suggesting that the LDLR was not completely downregulated.
36. Herijgers N, Van Eck M, Groot PHE, Hoogerbrugge PM, Van Berkel TJC. Effect • of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice. Arterioscl Thromb Vasc Biol 1997; 17:1995-2003. This study demonstrates that reconstitution of leukocyte expression of the LDLR in LDLR-deficient mice does not significantly influence atherosclerosis under conditions of severe hypercholesterolemia.
37. Mazzone T, Reardon C Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3. J Lipid Res 1994; 35:1345-1353.
38. Basu SK, Goldstein JL, Brown MS. Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages. Science 1983, 219:871-873.
39. Getz GS, Mazzone T, Soltys P, Bates SR. Atherosclerosis and apolipoprotein E An enigmatic relationship. Arch Pathol Lab Med 1988, 112:1048-1055
40. Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest 1995; 96:2170-2179.
41. Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, Harada K, et al. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest 1995; 95:469-476.
42. Longo DL, Davis ML Early appearance of donor type antigen-presenting cells in the thymuses of 1200 R radiation-induced bone marrow chimeras correlates with self-recognition of donor I region gene products. J Immunol 1983; 130:2525-2527.
43. Linton MF, Babaev VR, Gleaves LA, Atkinson JB, Fazio S Regression of atherosclerosis in apolipoprotein E deficient mice after bone marrow transplantation. Circulation 1996; 94 (Suppl):1-519
44. Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Gleaves LA, et al. • Increased atherosclerosis in C57BL/6 mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A 1997; 94:4647-4652. C57BL/6 mice reconstituted with apolipoprotein E null macrophages develop increased atherosclerosis in response to an atherogenic diet, although plasma lipid levels did not differ from values in transplanted controls. The results indicate an anti-atherogenic role for macrophage expression of apolipoprotein E in the artery wall.
45. Kraal G, Rep M, Janse M. Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study. Scand J Immunol 1987; 26:653-661.
46. Koo C, Wernette-Hammond ME, Innerarity TL. Uptake of canine β-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor. J Biol Chem 1986; 261:11194-11201.
47. Ellsworth JL, Kraemer FB, Cooper AD. Transport of β-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. J Biol Chem 1987; 262:2316-2325.
48. Koo C, Wernette-Hammond ME, Garcia Z, Malloy MJ, Uauy R, East C, et al. The uptake of cholesterol-rich remnant lipoproteins by human monocytederived macrophages is mediated by low density lipoprotein receptors. J Clin Invest 1988; 81:1332-1340.
49. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994, 93 1885-1893.
50. Fazio S, Babaev VR, Gleaves LA, Carter KJ, Linton MF. A direct role for macrophage LDL receptor in atherosclerotic lesion formation. Circulation 1997, 96 (Suppl):1-38
51. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA A leukocyte homologue of • the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice J Clin Invest 1998; 101:353-363. The authors demonstrate that macrophage expression of a leukocyte homologue of the IL-8 receptor reduces the accumulation of macrophages in arterial lesions of LDLR-deficient mice.